Drugs / SumayaVac-1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05644067 | Aug 2023 → Apr 2024 | malaria | Swiss Tropical & Public Health Institute | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SumayaVac-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05644067 ↗ |
| Known as | SUM-101 | “candidate malaria vaccine, SumayaVac-1 (SUM-101)” NCT05644067 ↗ |
| Modality | Vaccine | “candidate dual-stage malaria vaccine” NCT05644067 ↗ |
| Route | Intramuscular | “Vaccination: Intra-muscular injection of SumayaVac-1 (SUM-101)” NCT05644067 ↗ |